Cyclodextrin Inhibits Caveolin‐1 to Regulate CD4 + T Cell Subset Differentiation and Ameliorate Rheumatoid Arthritis Progression
Journal of Immunology Research · 2026-01 · 2026 (1)
DOI: 10.1155/jimr/7245795 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Immunology Research, online erschienen am 12.08.2026. Verfasst von Yajie Gao und 4 weiteren Autor:innen. Beteiligte Einrichtung: The Central Lab, The First Affiliated Hospital of Baotou Medical College, Baotou, Inner Mongolia, China, btmc.cn. Hauptthemen laut MEDLINE: Caveolin 1, Arthritis, Rheumatoid, CD4-Positive T-Lymphocytes, Arthritis, Experimental. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Inner Mongolia, Science and Technology Program of the Joint Fund of Scientific Research for the Public Hospitals of Inner Mongolia Academy of Medical Sciences.
Abstract (Originalsprache)
Objective
Rheumatoid arthritis (RA) is a systemic autoimmune disease characterized by dynamically recurring inflammatory episodes, and targeting T cells has been shown to effectively alleviate RA. Caveolin‐1 (CAV‐1) is widely distributed in the membrane structures of immune cells and participates in the differentiation and homeostasis of CD4 + T cell subsets through signal transduction; however, its role in RA has not yet been investigated. This study aimed to examine the expression pattern and clinical relevance of CAV‐1 in RA, and to elucidate its regulatory role in CD4 + T cell‐mediated immune imbalance during disease progression.
Methods
This retrospective clinical study was conducted to detect serum CAV‐1 levels in RA and healthy controls (HCs), characterize its expression in peripheral blood CD4 + T cells and synovial tissues, and evaluate its association with clinical parameters. A collagen‐induced arthritis (CIA) mouse model was established and treated with the CAV‐1 inhibitor hydroxypropyl‐β‐cyclodextrin (HP‐β‐CD). Joint pathology, CD4 + T cell infiltration, differentiation, and the expression of related inflammatory cytokines were assessed using histopathological and immunological approaches.
Results
CAV‐1 expression in serum, CD4 + T cells, and synovial tissues was significantly higher in RA than in HC and was positively correlated with anti‐cyclic citrullinated peptide antibody (Anti‐CCP) and rheumatoid factor (RF) levels. HP‐β‐CD treatment markedly relieved joint inflammation and structural damage in CIA mice, reduced CD4 + T cell infiltration, and significantly suppressed the differentiation of T helper 1, T helper 17, and regulatory T (Treg) cells, accompanied by decreased expression of IFN‐γ, IL‐17A, and transforming growth factor‐β (TGF‐β).
Conclusion
CAV‐1 is aberrantly upregulated in RA and contributes to disease pathogenesis by regulating CD4 + T cell differentiation. Targeting CAV‐1 may represent a promising strategy for RA diagnosis and immunomodulatory therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Central Lab, The First Affiliated Hospital of Baotou Medical College, Baotou, Inner Mongolia, China, btmc.cn.
- Department of Infectious Diseases, Inner Mongolia People's Hospital, Hohhot, Inner Mongolia, China, nmgyy.cn.
- Department of Rheumatology and Immunology, The First Affiliated Hospital of Baotou Medical College, Baotou, Inner Mongolia, China, btmc.cn.
ORCID-Profile: Yajie Gao, Peiyao Zhang, Yinping Huo, Yongfu Wang, Lingyan Zhu
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Inner Mongolia
- Science and Technology Program of the Joint Fund of Scientific Research for the Public Hospitals of Inner Mongolia Academy of Medical Sciences
- Young and Middle-aged Scientific and Technological Backbone Support Program of Baotou Medical College
Zitieren
APA
Gao, Y., Zhang, P., Huo, Y., Wang, Y., & Zhu, L. (2026). Cyclodextrin Inhibits Caveolin‐1 to Regulate CD4 + T Cell Subset Differentiation and Ameliorate Rheumatoid Arthritis Progression. Journal of Immunology Research, 2026(1). https://doi.org/10.1155/jimr/7245795
Vancouver
Gao Y, Zhang P, Huo Y, Wang Y, Zhu L. Cyclodextrin Inhibits Caveolin‐1 to Regulate CD4 + T Cell Subset Differentiation and Ameliorate Rheumatoid Arthritis Progression. Journal of Immunology Research. 2026;2026(1). doi:10.1155/jimr/7245795
BibTeX
@article{Gao2026,
author = {Gao, Yajie and Zhang, Peiyao and Huo, Yinping and Wang, Yongfu and Zhu, Lingyan},
title = {Cyclodextrin Inhibits Caveolin‐1 to Regulate CD4 + T Cell Subset Differentiation and Ameliorate Rheumatoid Arthritis Progression},
journal = {Journal of Immunology Research},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/jimr/7245795}
}
EUVIMED